[144] Privia Health Group, Inc. SEC Filing

Rhea-AI Filing Summary

PRVA reported a Form 144 notice for the proposed sale of 14,036 shares of Common Stock. The filing lists the sale method as Restricted Stock Vesting and identifies the issuer as the seller on 05/08/2026. The filing also discloses multiple completed Common stock sales by Parth Mehrotra in March 2026, with individual transactions and gross proceeds reported for each date.

Insights

Securities Compliance Analyst

Form 144 notifies proposed resale of restricted shares under Rule 144.

Rule 144 notices are administrative disclosures that report an intent to sell restricted or control securities; here the filing lists 14,036 shares tied to Restricted Stock Vesting with an issuer designation and a 05/08/2026 date.

Past sale activity by the same reporting individual is shown for March 2026; timing and actual sale methods depend on compliance with Rule 144 conditions and are not detailed beyond the notice.

Corporate Governance Specialist

The filing documents routine insider dispositions and a vesting-triggered sale notice.

The record lists multiple March 2026 transactions by Parth Mehrotra with per-transaction share counts and gross proceeds, indicating prior sales activity within the quarter.

Cash-flow treatment and any transfer restrictions are not described in the excerpt; subsequent filings or broker reports would show settlement details.

Key Figures

Proposed shares to be sold: 14,036 shares March 6, 2026 sale: 21,440 shares March 9, 2026 sale: 41,999 shares +4 more

7 metrics

Proposed shares to be sold 14,036 shares Securities To Be Sold; Restricted Stock Vesting; <date>05/08/2026</date>

March 6, 2026 sale 21,440 shares Completed Common sale by Parth Mehrotra on <date>03/06/2026</date>

March 9, 2026 sale 41,999 shares Completed Common sale by Parth Mehrotra on <date>03/09/2026</date>

March 10, 2026 sale 21,097 shares Completed Common sale by Parth Mehrotra on <date>03/10/2026</date>

March 12, 2026 sale 26,763 shares Completed Common sale by Parth Mehrotra on <date>03/12/2026</date>

March 13, 2026 sale 27,229 shares Completed Common sale by Parth Mehrotra on <date>03/13/2026</date>

March 16, 2026 sale 26,509 shares Completed Common sale by Parth Mehrotra on <date>03/16/2026</date>

Key Terms

Form 144, Restricted Stock Vesting, Issuer

3 terms

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Common | 05/08/2026 | Restricted Stock Vesting"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Issuer regulatory

"Common | 05/08/2026 | Restricted Stock Vesting | Issuer"

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	14036	317262.72	126012374	05/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/08/2026	Restricted Stock Vesting	Issuer			14036	05/08/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Parth Mehrotra 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	03/06/2026	21440	496357.44
Parth Mehrotra 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	03/09/2026	41999	960197.55
Parth Mehrotra 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	03/10/2026	21097	479144.34
Parth Mehrotra 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	03/12/2026	26763	586096.32
Parth Mehrotra 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	03/13/2026	27229	586096.06
Parth Mehrotra 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	03/16/2026	26509	586108.69

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)